OR
Oruka Therapeutics, Inc.
ORKA · NASDAQ
$93.38 -1.90% (-$1.81)
1M -7.28%
Market Cap $5.90B
P/E Ratio -
Div. Yield -
ROE 20.76%
Piotroski F-Score Weak
2/9Valuation
34 /100
Fair P/B 5.29x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 13.88%
ROE 20.76%
ROA 11.66%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 38.51x
Int. coverage N/A
Stability
50 /100
Moderate Beta -0.39x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ORKA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lawrence Otto Klein
Employees
68
Headquarters
Menlo Park
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report